About this trial
This prospective case series study aims to clinically and radiographically evaluate the effectiveness of the socket shield technique combined with concentrated growth factors (CGF) in immediate implant placement in the esthetic zone. Outcomes will include crestal bone level changes assessed by CBCT and implant stability measured using Osstell.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years old. (Younis, W., & El-Rashidy, A. 2020).
Both male and female patients.
Maxillary, anterior and premolar segment.
Disqualifiers
A medical history that contraindicates oral surgical treatment such as (uncontrolled/untreated diabetes mellitus, immuno-compromised status, radio or chemotherapy of the oral and maxillofacial region, treatment with oral and/or intravenous bisphosphonates).
Presence of active or untreated periodontal disease.
Vertical root fractures involving the buccal aspect.
Tooth /teeth with horizontal fractures below bone level.
Trial design
Single group
Treatments tested in this trial
Immediate implant placement with Socket Shield Technique and CGF
Procedure/SurgeryPartial extraction therapy using the socket shield technique followed by immediate implant placement. Concentrated growth factors prepared from autologous blood will be packed in the jumping gap to enhance bone regeneration and healing.
Treatment groups
Trial outcomes
Primary outcomes
Crestal bone level
Radiographic evaluation of crestal bone level changes around the implant using CBCT, measured in millimeters (mm).
Secondary outcomes
Implant stability
Implant stability will be assessed using resonance frequency analysis with the Osstell device and recorded as Implant Stability Quotient (ISQ). ISQ values range from 1 to 100, where higher values indicate greater implant stability and a better outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: